CHPA and PCPC Comments Regarding Content and Format of Labeling for Human Nonprescription Drug Products Share page: Docket Number: FDA-2022-D-1837 Download Document Issues: OTC Medicines Other Issues Labeling Related Posts Press Releases and Statements CHPA Applauds Vermont for Passing Sun Safety Bill Empowering Students to Better Protect their Skin May 8, 2024 Press Releases and Statements Tennessee Expands Access to OTC Cold & Allergy Medications Containing PSE May 7, 2024 Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024